Prem Adial
About Prem Adial
Prem Adial serves as the Associate Director at Kite Pharma, where he has worked since 2020. He has extensive experience in marketing and product management across various healthcare companies, including Beckman Coulter Diagnostics, Abbott, and GE Healthcare.
Work at Kite Pharma
Prem Adial has been serving as Associate Director at Kite Pharma since 2020. He is based in Santa Monica, California. In this role, he utilizes his extensive experience in marketing and product management within the pharmaceutical sector to contribute to the company's objectives.
Previous Experience in Marketing and Product Management
Prior to his current position, Prem Adial held several roles in prominent companies. He worked at Beckman Coulter Diagnostics as Senior Marketing Manager for one year, focusing on marketing strategies. He also served as Product Manager at Abbott for two years, overseeing product development initiatives. His tenure at GE Healthcare included multiple roles, such as Product Manager and Digital Marketing Leader, where he managed product launches and marketing campaigns.
Education and Expertise
Prem Adial earned his Master of Business Administration (MBA) from the University of Southern California - Marshall School of Business, completing his studies from 2008 to 2011. He also holds a Bachelor of Science (B.S.) degree from the University of California, Los Angeles, which he obtained from 1999 to 2004. His educational background supports his expertise in launching products in the pharmaceutical, biotechnology, and medical device sectors.
Career Development at Amgen and GE Healthcare
Prem Adial's career includes significant roles at Amgen, where he worked as Senior Business Analyst and Sales Operations Manager. His experience at GE Healthcare was extensive, involving positions such as Program Manager and Strategic Marketing Manager within the Experienced Commercial Leadership Program. These roles allowed him to develop a strong foundation in both analytical and creative aspects of marketing.